Skip to content
10-Q

Quarterly Report

Innoveren Scientific, Inc.

0001493152-23-018504

← back to feed
Filed
May 22, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 19, 2023 628.12K sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$361.99K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$884.26K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $116K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$11.33M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$9.36M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$4.13M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$4.66M
Current Liabilities Q1 2023 · Mar 31, 2023 $9.66M
Current Liabilities Q1 2023 · Dec 31, 2022 $7.48M
Total Liabilities Q1 2023 · Mar 31, 2023 $11.68M
Total Liabilities Q1 2023 · Dec 31, 2022 $9.49M
Current Assets Q1 2023 · Mar 31, 2023 $303.3K
Current Assets Q1 2023 · Dec 31, 2022 $83.85K
Total Assets Q1 2023 · Mar 31, 2023 $349.36K
Total Assets Q1 2023 · Dec 31, 2022 $137.36K
Eps Basic Q1 2023 · Mar 31, 2023 −$3.38
Eps Basic Q1 2023 · Mar 31, 2022 −$23.01
Net Income Q1 2023 · Mar 31, 2023 −$2.09M
Net Income Q1 2023 · Mar 31, 2022 −$3.89M
Operating Income Q1 2023 · Mar 31, 2023 −$420.68K
Operating Income Q1 2023 · Mar 31, 2022 −$790.15K
Gross Profit Q1 2023 · Mar 31, 2022 $293.06K
Revenue Q1 2023 · Mar 31, 2022 $379.56K